4/A//SEC Filing
Arthur David J. 4/A
Accession 0001615219-22-000144
CIK 0001615219other
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 5:42 PM ET
Size
6.4 KB
Accession
0001615219-22-000144
Insider Transaction Report
Form 4/AAmended
Arthur David J.
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2022-11-03$1.73/sh+10,000$17,340→ 21,026 total
Holdings
- 564(indirect: By son)
Common Stock
- 552(indirect: By daughter)
Common Stock
Footnotes (1)
- [F1]These shares were acquired under the Salarius Pharmaceuticals, Inc. 2015 Employee Stock Purchase Plan, as amended, in transactions that were exempt under both Rule 16b-3(d) and Rule Rule 16b-3(c)
Documents
Issuer
Salarius Pharmaceuticals, Inc.
CIK 0001615219
Entity typeother
Related Parties
1- filerCIK 0001769331
Filing Metadata
- Form type
- 4/A
- Filed
- Nov 7, 7:00 PM ET
- Accepted
- Nov 8, 5:42 PM ET
- Size
- 6.4 KB